Eclipse - OmicsDI

Show results for

Proteomics (1590)
Unknown (416)
Metabolomics (99)
Genomics (37)
Transcriptomics (29)
Other (5)
Genomic (3)
Clinical (1)

Organisms

Schizosaccharomyces pombe (1170)
Sinorhizobium meliloti BL225C (1170)
Sus scrofa domesticus (1170)
Saccharomyces cerevisiae (1170)
Staphylococcus aureus (1170)
Rattus norvegicus (1170)
Escherichia coli (1170)
Methylohalobius crimeensis 10Ki (1170)
Homo sapiens (1170)
Homo sapiens (24)
Mus musculus (12)
Thermus thermophilus HB8 (3)
unidentified (3)
Escherichia coli (3)
Aspergillus fumigatus (2)
Saccharomyces cerevisiae (2)
Oidiodendron maius (1)
Serendipita vermifera (1)
Leishmania amazonensis (1)
Capra hircus (1)
Rattus norvegicus (1)
Macaca mulatta (1)
Bos taurus (1)
Montipora capitata (1)
Oleidesulfovibrio alaskensis G20 (1)
Nakaseomyces glabratus (1)
Mycobacterium tuberculosis (1)
Amphistegina lobifera (1)
Achromobacter xylosoxidans (1)
Pseudomonas savastanoi pv. phaseolicola (1)

Organisms

Homo sapiens (14)
Mus musculus (13)
Aspergillus fumigatus (2)
Caenorhabditis elegans (2)
Macaca mulatta (1)
Bos taurus (1)
Staphylococcus aureus (1)

Repository

pride (1170)
MassIVE (411)
MetaboLights (77)
ENA (37)
biostudies-arrayexpress (24)
GNPS (22)
geo (9)
jPOST (7)
dbGaP (3)
iProX (2)
PanoramaPublic (1)

Tissue

Cell culture (284)
Epithelial cell (64)
Brain (61)
Liver (38)
Blood plasma (33)
Permanent cell line cell (33)
Heart (30)
Fibroblast (27)
T cell (18)
Blood serum (17)
Skeletal muscle (17)
Plant cell (16)
Whole body (16)
Primary cell (16)
Blood (16)
Leaf (14)
Blood cell (14)
Stem cell (13)
Hepatocyte (13)
Lung (13)
Kidney (13)
Cell suspension culture (12)
Monocyte (12)
Seedling (11)
Skin (11)
Early embryonic cell (11)
Macrophage (11)
B cell (11)
Embryonic stem cell (10)
Colon (10)

Disease

Disease free (34)
Acute leukemia (17)
Breast cancer (12)
Cardiovascular system disease (9)
COVID-19 (9)
Colon cancer (9)
Cervix carcinoma (8)
Obesity (7)
Type 2 diabetes mellitus (7)
Lymphoma (6)
Malignant neoplasm of ovary (6)
Alzheimer's disease (5)
Plasmodium falciparum malaria (5)
Pancreatic ductal adenocarcinoma (5)
Hepatocellular carcinoma (4)
Non-small cell lung carcinoma (4)
Lung adenocarcinoma (4)
Prostate adenocarcinoma (4)
Melanoma (4)
Cystic fibrosis (4)
Age related macular degeneration (3)
Type 1 diabetes mellitus (3)
Congenital disorder of glycosylation (3)
Severe acute respiratory syndrome (3)
Prostate cancer (3)
Human immunodeficiency virus infectious disease (3)
Chronic lymphocytic leukemia (3)
Parkinson's disease (3)
Moderate (1)
Colorectal Neoplasms (1)

Technology Type

Mass Spectrometry (1170)
Bottom-up proteomics (500)
Shotgun proteomics (361)
Data-dependent acquisition (333)
Data-independent acquisition (101)
Affinity purification coupled with mass spectrometry proteomics (92)
Chemical cross-linking coupled with mass spectrometry proteomics (61)
Mass spectrometry (55)
Top-down proteomics (33)
SWATH MS (31)
Mass spectrometry assay (23)
SRM/MRM (22)
Gel-based experiment (22)
Immunopeptidomics (8)
Glycoproteomics (7)
Affinity proteomics (7)
HDMSE (4)
Proteogenomics (3)
Mass spectrometry imaging (3)
All-ion fragmentation (3)
RNA mass spectrometry (2)
MSE (2)
NMR spectroscopy (1)

Instrument Platform

Orbitrap Eclipse (411)
Orbitrap Fusion Lumos (32)
Q Exactive HF (13)
Orbitrap Exploris 480 (9)
TimsTOF HT (6)
Orbitrap Ascend (6)
Q Exactive (6)
UltrafleXtreme (5)
Orbitrap Fusion (5)
TimsTOF Pro (4)
Orbitrap Astral (3)
TripleTOF 6600 (3)
Illumina HiSeq 4000 (2)
6470 Triple Quadrupole LC/MS (Agilent instrument model) (2)
6520A Quadrupole Time-of-Flight LC/MS (2)
MS: Orbitrap Eclipse (2)
LC: Vanquish Neo UHPLC System (2)
Orbitrap Eclipse Tribrid (2)
ZenoTOF 7600 (2)
Nikon Eclipse Ti2 with brightfield and fluorescence capacity (TRITC) (1)
Leica Biosystems Cryostat (1)
Bio-Rad CFX96 Real-time System (1)
Illumina HiSeq 2500 (1)
Illumina HiSeq 2000 (1)
6546 Quadrupole Time-of-Flight LC/MS (Agilent instrument model) (1)
6546 Quadrupole Time-of-Flight LC\/MS (Agilent instrument model) (1)
6546 Quadrupole Time-of-Flight LC\\\/MS (Agilent instrument model) (1)
7820A/5977B GC/MS (Agilent instrument model) (1)
Agilent iFunnel 6550 Q-ToF LC/MS System (1)
Impact II (1)

Publication Date

2025 (429)
2024 (354)
2026 (354)
2023 (226)
2022 (154)
2021 (104)
2020 (15)
2018 (6)
2016 (6)
2015 (6)
2019 (6)
2017 (4)
2012 (3)
2014 (2)
2010 (2)
2009 (2)
2013 (1)
2011 (1)
2008 (1)
2007 (1)

CHEBI ID

CHEBI:16335 (14)
CHEBI:16704 (13)
CHEBI:17596 (13)
CHEBI:30769 (11)
CHEBI:16750 (11)
CHEBI:27897 (11)
CHEBI:16811 (11)
CHEBI:18237 (11)
CHEBI:29016 (11)
CHEBI:15428 (10)
CHEBI:15741 (10)
CHEBI:22660 (10)
CHEBI:28300 (10)
CHEBI:25094 (10)
CHEBI:16610 (9)
CHEBI:17822 (9)
CHEBI:22653 (9)
CHEBI:17368 (9)
CHEBI:28044 (9)
CHEBI:18095 (8)
CHEBI:27732 (8)
CHEBI:28790 (8)
CHEBI:30763 (8)
CHEBI:15891 (8)
CHEBI:17509 (8)
CHEBI:17750 (8)
CHEBI:16856 (8)
CHEBI:16449 (8)
CHEBI:27266 (8)
CHEBI:26271 (8)

Metabolite Name

Citric acid (8)
Adenosine (8)
Glycerophosphocholine (7)
Taurine (7)
Guanosine (7)
Inosine (7)
Uridine (7)
Lactic acid (6)
Methionine (6)
Spermidine (6)
Glutamine (6)
Glycine (6)
L-Phenylalanine (6)
Betaine (5)
Nicotinic acid (5)
Benzoic acid (5)
Succinic acid (5)
L-Tyrosine (5)
Lysine (5)
Pipecolic acid (5)
Asparagine (5)
Tyrosine (5)
Serine (5)
1-methyladenosine (5)
Proline (5)
L-Tryptophan (5)
Hypoxanthine (5)
Creatinine (5)
L-Proline (5)
Glutathione (5)

First Public Date

2026 (7)
2025 (7)
2024 (5)
2017 (4)
2023 (3)
2022 (3)
2021 (3)
2014 (2)
2016 (1)
2015 (1)
2013 (1)

Classification

fungi (2)
bacteria (1)

Modification

N6 (4)
4 (1)
N6-dimethyl-L-lysine (1)

Study status

Recruiting (1)

Study type

Transcription profiling by array (13)
RNA-seq of coding RNA (6)
Unknown experiment type (1)
Spatial transcriptomics by high-throughput sequencing (1)
RIP-seq (1)
Proteomic profiling by array (1)
RNA-seq of coding RNA from single cells (1)
Observational (1)

Release Date

2020 (41)
2025 (39)
2023 (38)
2022 (38)
2021 (37)
2024 (32)
2019 (31)
2017 (27)
2014 (25)
2016 (24)
2018 (23)
2015 (23)
2011 (13)
2012 (9)
2013 (7)
2010 (7)
2008 (6)
2009 (5)
2007 (4)
2026 (4)
2005 (3)
2006 (1)
2004 (1)
2003 (1)
2000 (1)

Lab affiliation

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA (37)
The University of Melbourne (18)
NCI/NIH CSB (10)
Northwestern University, Department of Chemistry (8)
Department of Laboratory Medicine and Pathology Mayo Clinic, Rochester, Minnesota 55905 United States (7)
Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne 3000, Australia (7)
Department of Radiology Canary Center at Stanford for Cancer Early Detection Stanford School of Medicine Stanford University (7)
Cornell University (7)
Proteomics & Metabolomics Facility, Center for Open Research Resources & Equipment University of Connecticut Storrs, CT 06269 (6)
Carnegie Mass Spectrometry Facility (5)
MBG, Aarhus University, Denmark (4)
Translational Genomics Research Institute (4)
Mass Spectrometry & Proteomics Core Facility (MSPCF) Institute for Research in Biomedicine (IRB Barcelona) Barcelona Institute of Science and Technology (BIST) C/ Baldiri Reixac, 10-12 08028 Barcelona - Spain. (4)
Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver V5Z 1L3, Canada. (4)
Department of Cell Biology, Harvard Medical School (4)
Harvard Medical School (4)
Proteomics Center, Erasmus MC (4)
Department of Cell Biology, Harvard Medical School, Boston MA (4)
Head of the Curie Institute Mass Spectrometry Platform (4)
Department of Plant Biology, Carnegie Institution for Science, Stanford, California, USA (3)
Human Technopole, 20157, Milan, Italy (3)
Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA (3)
University of Cincinnati College of Medicine (3)
Kobilka Institute of Innovative Drug Discovery, School of Medicine, The Chinese University of Hong Kong, Shenzhen, Shenzhen 518172, China. (3)
BBE, Tsui-Fen Chou's lab, Caltech, USA (3)
Calico Life Sciences (3)
University of Pennsylvania, Department of Biology (3)
Signalling ISP, Babraham Institute, Cambridge, UK (3)
Head Proteomics Group, Leiden University Medical Center, Center for Proteomics and Metabolomics, PO Box 9600, Postal zone P1-Q, 2300 RC Leiden, The Netherlands (3)
Carnegie MS facility (3)

Location

United States (1)

Previous page
1 / 218
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 218
Next page

Sort by:

Relevance

Page size

Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE)

ECLIPSE was a longitudinal observational study of 2164 COPD subjects and a smaller number of smoking controls (337) and nonsmoking controls (245) followed regularly for three years, with three chest CT scans (at baseline, one year, and three years) (Vestbo, European Respiratory Journal 2008; 31: ...

phs001252 | dbGaP

Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE)

PRJNA354105 | ENA

Induced Sputum Genes Associated With Spirometroc and Radiological Disease Severity in COPD Ex-smokers

Induced sputum is used to sample inflammatory cells, predominantly neutrophils and macrophages, from the airways of COPD patients. Our aim was to identify candidate genes associated with the degree of airflow obstruction and the extent of emphysema by expression profiling, and then to confirm these ...

ORGANISM(S): Homo sapiens

2010-06-16 | E-GEOD-22148 | biostudies-arrayexpress

NHLBI TOPMed: Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE)

PRJNA414680 | ENA

NHLBI TOPMed: Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE)

PRJNA414681 | ENA

Combining biomarkers of clot resolution and alveolar basement membrane destruction predicts mortality in the ECLIPSE COPD cohort.

Not available

S-EPMC7530580 | biostudies-literature

Is an eclipse described in the Odyssey?

Not available

S-EPMC2440358 | biostudies-literature